Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

RTTNews | 510 days ago
Stocktwits
Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

(RTTNews) - Astellas Pharma Inc. announced Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.

The positive CHMP opinion is based on the results from the Phase 3 EMBARK trial.

The positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines in all 27 European Union (EU) member states as well as Iceland, Liechtenstein and Norway.

Astellas is also discussing the EMBARK data with other regulatory authorities to support additional license applications for XTANDI in this indication in 2024 and beyond.

Tags: ALPMY
Stocktwits
read more
Australian Dollar Advances On Robust Employment Data

Australian Dollar Advances On Robust Employment Data

The Australian dollar strengthened against some major counterparts in the Asian session on Thursday, after data showed that the Australia's unemployment rate dropped in July and employment increased sharply, suggesting that the labor market conditions remain strong.
RTTNews | 1h 26min ago
Yen Rises Amid BoJ Rate Hike Expectation

Yen Rises Amid BoJ Rate Hike Expectation

The Japanese yen strengthened against other major currencies in the Asian session on Thursday, as the Bank of Japan (BoJ) raised its inflation outlook in July and kept the door open for an imminent interest rate hike by the end of current year.
RTTNews | 1h 46min ago
Tools
Kalender Ekonomi
Jam pasar
Suku bunga
Kalender hari libur
Pasar Valas
Forex Volatility
Forex Correlation
Berita Forex
Analisis Forex
COT Data
Likuiditas
Kalkulator Forex
Forex Heat Map
Heatmap indikator
Komunitas
Komunitas
Sistems
Most Popular Systems
Strategies
Kontes
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviu
Pialang
Perusahaan Prop Trading
VPS Services
Signal Providers
EA Programming Services
Program Afiliasi
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Bursa Kripto
Kursus trading
Pialang
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Siaran Pers
Platform
Widget
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.